ClinicalThought
View More
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Expert commentary on real-world and trial data on treating RA after failing biologic and targeted small-molecule DMARDs, from EULAR 2020 by CCO
Eric M. Ruderman, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: August 27, 2020
Expired: August 26, 2021
Expert commentary on key studies in RA comorbidities from EULAR 2020 as reported by CCO
Paul Emery, MA, MD, FRCP
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Released: August 24, 2020
Expired: August 23, 2021
EULAR 2020 on SELECT-CHOICE: upadacitinib vs abatacept for active rheumatoid arthritis with prior inadequate response or intolerance to bDMARDs as reported by CCO
New from EULAR 2020: risk of venous thromboembolism (DVT or PE) varies by DAS28 in patients with rheumatoid arthritis as reported by Clinical Care Options (CCO)
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.